Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease (PARADE)

Nycomed

Status: Completed

Conditions: Gastroesophageal Reflux Disease

Treatments: Drug: Pantoprazole

Study type: Observational

Funder types: Industry

Identifiers

NCT00829738

P2-9999-011-DE

Details and patient eligibility

About

The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.

Enrollment: 4,188 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Main inclusion criteria:

• Outpatients with gastroesophageal reflux disease (GERD)

Main exclusion criteria:

• Criteria as defined in the Summary of Product Characteristics

Trial design

4,188 participants in 1 patient group

Group 1

Description:

All patients enrolled

Treatment:

Drug: Pantoprazole